Bowles J, Nyx E, Kalicum J, Kerr T Qualitative findings from North America's first drug compassion club PLoS One, 2024. PubMed

Robinson S, Brohman I, van Draanen J, Kushner R, Fairbairn N, Glegg S Innovations to the ECHO model to enhance reach and network-building among addiction clinicians in Western Canada Addict Sci Clin Pract, 2024. PubMed

Nosyk B, Min JE, Homayra F, Kurz M, Guerra-Alejos BC, Yan R, Piske M, Seaman SR, Bach P, Greenland S, Karim ME, Siebert U, Bruneau J, Gustafson P, Kampman K, Korthuis PT, Loughin T, McCandless LC, Platt RW, Schnepel KT, Socías ME Buprenorphine/naloxone vs methadone for the treatment of opioid use disorder JAMA, 2024. PubMed

Swaich A, Ignatieff D, Milloy MJ, Choi JC, Kerr T, Hayashi K Impacts of the COVID-19 pandemic on the availability and retail price of unregulated drugs in Vancouver, Canada: an interrupted time-series analysis, 2018-2022 Int J Drug Policy, 2024. PubMed

Lavalley J, Steinhauer L, Bundy DB, Kerr T, McNeil R "They talk about it like it's an overdose crisis when in fact it's basically genocide": The experiences of Indigenous peoples who use illicit drugs in Vancouver's Downtown Eastside neighbourhood Int J Drug Policy, 2024. PubMed

Goodyear T, Jenkins E, Fast D, Oliffe JL, Kia H, Katriana I, Knight R Homes of substance: drugs and the making of home/lessness for 2S/LGBTQ+ youth Soc Sci Med, 2024. PubMed

Eekhoudt CR, Sandhu M, Mniszak C, Goodyear T, Turuba R, Marchand K, Barbic S, Fast D Looking beyond drugs: a scoping review of recovery in the context of illicit substance use among adolescents and young adults Int J Drug Policy, 2024. PubMed

James H, Morgan J, Nolan S Characterising individuals with a substance use disorder accessing hospital-based addiction care: preliminary description of the outcomes for patients accessing addiction care prospective cohort study Drug Alcohol Rev, 2024. PubMed

Ivsins A, Mansoor M, Bowles J, Bardwell G Reasons for enrolling in safer supply programs: a longitudinal qualitative study on participant goals and related outcomes in the MySafe program J Stud Alcohol Drugs, 2024. PubMed

Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Lim R, Socías ME Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder in Canada Am J Addict, 2024. PubMed